RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      적절하게 조절되지 않는 중증 천식환자에서 급성 악화 유형과 사망 및 의료비 발생 현황 = Types of Exacerbation, Case-fatality and Medical Costs in Patients with Severe and Uncontrolled Asthma

      한글로보기

      https://www.riss.kr/link?id=A106408335

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Patients with severe and uncontrolled asthma are at high risk for severe exacerbation and death, and are knownto have significantly more health care utilization than well-controlled patients. This study aims to report types ofexacerbation, case-fatality and medical costs in patients with severe and uncontrolled asthma. We used Health InsuranceReview and Assessment Service-National Patient Sample 2016~2017. Four types of exacerbation were defined:exacerbation requiring corticosteroid burst, exacerbation requiring emergency room visit, exacerbation requiring generalward admission, and exacerbation requiring intensive care unit (ICU) admission. The 28 day case-fatality was calculatedfor exacerbation requiring general ward and ICU admission, respectively. The medical cost by types of exacerbation werecalculated as total medical cost incurred during the exacerbation episodes. The 28 day case-fatalities for exacerbationrequiring general ward and ICU admission were 0.033 and 0.167, respectively. The medical cost per episode of the abovefour exacerbations were 78,818 Korean won (KRW), 561,832 KRW, 1,923,265 KRW and 11,215,063 KRW, respectively.
      We reported types of exacerbation, 28 day case-fatality and medical costs in patients with severe and uncontrolled asthma.
      This study was significant because it clearly defined and distinguished the patient group and each exacerbation episodes.
      번역하기

      Patients with severe and uncontrolled asthma are at high risk for severe exacerbation and death, and are knownto have significantly more health care utilization than well-controlled patients. This study aims to report types ofexacerbation, case-fatali...

      Patients with severe and uncontrolled asthma are at high risk for severe exacerbation and death, and are knownto have significantly more health care utilization than well-controlled patients. This study aims to report types ofexacerbation, case-fatality and medical costs in patients with severe and uncontrolled asthma. We used Health InsuranceReview and Assessment Service-National Patient Sample 2016~2017. Four types of exacerbation were defined:exacerbation requiring corticosteroid burst, exacerbation requiring emergency room visit, exacerbation requiring generalward admission, and exacerbation requiring intensive care unit (ICU) admission. The 28 day case-fatality was calculatedfor exacerbation requiring general ward and ICU admission, respectively. The medical cost by types of exacerbation werecalculated as total medical cost incurred during the exacerbation episodes. The 28 day case-fatalities for exacerbationrequiring general ward and ICU admission were 0.033 and 0.167, respectively. The medical cost per episode of the abovefour exacerbations were 78,818 Korean won (KRW), 561,832 KRW, 1,923,265 KRW and 11,215,063 KRW, respectively.
      We reported types of exacerbation, 28 day case-fatality and medical costs in patients with severe and uncontrolled asthma.
      This study was significant because it clearly defined and distinguished the patient group and each exacerbation episodes.

      더보기

      참고문헌 (Reference)

      1 최인선, "중증 천식발작 회복 후 임상 경과 - 제3보" 대한 소아알레르기 호흡기학회 4 (4): 340-345, 2016

      2 권성신, "중증 급성 천식 악화로 중환자실에 입원한 환자의 사망위험 요인" 대한 소아알레르기 호흡기학회 3 (3): 432-438, 2015

      3 Bavbek, S., "on behalf of the ADVISE Study Group: A cost-of-illness study estimating the direct cost per asthma exacerbation in Turkey" 105 (105): 541-, 2011

      4 Peters, S. P., "Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment" 100 (100): 1139-, 2006

      5 Roberts, N. J., "Time trends in 30 day case-fatality following hospitalisation for asthma in adults in Scotland: a retrospective cohort study from 1981 to 2009" 107 (107): 1172-, 2013

      6 Hoskins, G., "Risk factors and costs associated with an asthma attack" 55 : 19-, 2000

      7 Chung, K. F., "International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma" 43 (43): 343-, 2014

      8 Lee, Y. J., "Health care utilization and direct costs in mild, moderate, and severe adult asthma: a descriptive study using the 2014 South Korean health insurance database" 39 (39): 527-, 2017

      9 Global Initiative for Asthma, "Global Strategy for Asthma Management and Prevention"

      10 Watson, L., "Factors associated with mortality after an asthma admission: a national United Kingdom database analysis" 101 (101): 1659-, 2007

      1 최인선, "중증 천식발작 회복 후 임상 경과 - 제3보" 대한 소아알레르기 호흡기학회 4 (4): 340-345, 2016

      2 권성신, "중증 급성 천식 악화로 중환자실에 입원한 환자의 사망위험 요인" 대한 소아알레르기 호흡기학회 3 (3): 432-438, 2015

      3 Bavbek, S., "on behalf of the ADVISE Study Group: A cost-of-illness study estimating the direct cost per asthma exacerbation in Turkey" 105 (105): 541-, 2011

      4 Peters, S. P., "Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment" 100 (100): 1139-, 2006

      5 Roberts, N. J., "Time trends in 30 day case-fatality following hospitalisation for asthma in adults in Scotland: a retrospective cohort study from 1981 to 2009" 107 (107): 1172-, 2013

      6 Hoskins, G., "Risk factors and costs associated with an asthma attack" 55 : 19-, 2000

      7 Chung, K. F., "International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma" 43 (43): 343-, 2014

      8 Lee, Y. J., "Health care utilization and direct costs in mild, moderate, and severe adult asthma: a descriptive study using the 2014 South Korean health insurance database" 39 (39): 527-, 2017

      9 Global Initiative for Asthma, "Global Strategy for Asthma Management and Prevention"

      10 Watson, L., "Factors associated with mortality after an asthma admission: a national United Kingdom database analysis" 101 (101): 1659-, 2007

      11 Chastek, B., "Economic burden of illness among patients with severe asthma in a managed care setting" 22 (22): 848-, 2016

      12 Papiris, S., "Clinical review: severe asthma" 6 (6): 30-, 2001

      13 조유숙, "Characteristics of Adult Severe Refractory Asthma in Korea Analyzed From the Severe Asthma Registry" 대한천식알레르기학회 11 (11): 43-54, 2019

      14 Kim, L., "A guide for the utilization of health insurance review and assessment service national patient samples" 36 : e2014008-, 2014

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2027 평가예정 재인증평가 신청대상 (재인증)
      2021-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2018-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2003-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2002-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.2 0.2 0.22
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.23 0.18 0.403 0.02
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼